Artificial Intelligence (AI) is reshaping the future of medical device compliance, and nowhere is this more evident than in Post-Market Surveillance (PMS).
As global regulatory demands grow in scope and intensity, medical device manufacturers are turning to AI to unlock new efficiencies, improve accuracy, and future-proof their operations.
But while AI holds immense potential, it also introduces new challenges. In this blog, we explore how to integrate AI thoughtfully into PMS workflows, where it adds the most value, and where caution is still required.
Why AI, why now?
Under frameworks like the EU Medical Device Regulation (EU MDR), In Vitro Diagnostic Regulation (EU IVDR), and now the UK’s PMS Statutory Instrument, PMS has become a continuous, data-rich, and resource-intensive task. Teams are expected to monitor global safety data, respond quickly to complaints, and feed updates into risk management, performance evaluation, and clinical documentation.
This environment creates the perfect conditions for AI:
- Large volumes of structured data
- Time-consuming, repetitive tasks
- Tight deadlines for compliance reports
- A need for real-time signal detection
With AI, manufacturers can automate the heavy lifting, enabling compliance teams to focus on interpretation and decision-making.
Where AI can add value in PMS
AI tools are already helping device manufacturers improve speed and scalability in key areas of PMS. Here’s where adoption is gaining traction:
-
Automated Literature Screening
AI-powered platforms can scan and categorize thousands of scientific publications and safety reports across multiple databases. They can identify relevant articles based on device name, technology, intended use, and even specific components.
Benefits:
-
Saves hours of manual search
-
Reduces risk of missed data
-
Ensures consistency across literature reviews
-
Signal Detection and Trend Analysis
Machine learning models can process large sets of complaint, adverse event, and vigilance data to identify patterns, long before a human reviewer might notice.
Benefits:
-
Early identification of emerging risks
-
Data-driven risk classification
-
Prioritization of critical safety concerns
-
Drafting PMS Documents
Natural language processing (NLP) tools can generate draft summaries, identify gaps in content, and propose structure for key PMS deliverables like PSURs, PMCF reports, and SSCPs.
Benefits:
-
Faster document production
-
Template consistency
-
Reduced burden on technical writers
-
Regulatory Intelligence Monitoring
AI can scan regulatory websites and databases, tracking changes in guidance from global authorities (e.g. EU, UK, FDA), and provide summarised updates to your RA/QA teams.
Benefits:
-
Real-time alerts on regulatory updates
-
Global compliance awareness
-
Supports multi-jurisdictional strategies
AI is not a set-it-and-forget-it solution
With great power comes great responsibility. While AI is a powerful tool, human oversight remains non-negotiable, especially in regulated industries like medical devices.
- Watch out for AI hallucinations
AI models can sometimes fabricate sources or generate plausible but false information. It’s important to never rely on AI output without expert validation.
- Maintain expert oversight
Subject Matter Experts (SMEs) and medical writers must always review and approve any AI-generated content, especially for critical regulatory filings.
- Transparency is key
Regulators (such as Notified Bodies and the MHRA) will increasingly expect you to document:
- What AI tools you used
- How they were validated
- What checks were performed
- Where human review was involved
Getting started: steps to integrate AI into PMS
If you’re considering AI, it’s best to start small, learn fast, and scale smart. Here’s how:
-
Pilot a focus area
Begin with one PMS function, for example literature review or complaint trend analysis. Measure impact and build your case.
-
Choose tools carefully
Opt for AI tools that are validated, explainable, and configurable. Avoid black-box models with no traceability.
-
Upskill your team
Success with AI isn’t just about tech, it’s about human expertise. Train RA/QA staff to collaborate with AI, not just use it.
-
Plan for auditability
Maintain clear logs of:
- AI input and output
- Human interventions
- QA processes
These will be vital in future audits or product liability cases.
The bottom line
AI isn’t here to replace your regulatory or quality teams, it’s here to amplify their power. Used wisely, it can dramatically improve the speed, accuracy, and agility of your PMS processes, turning compliance into a strategic asset.
As medical device regulations grow more complex, manufacturers that embrace AI thoughtfully, without cutting corners, will be better positioned to meet global requirements, reduce operational burden, and improve patient safety outcomes.